Rafael A. Del Orbe

Barakaldo, PV, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Impact of Atrial Fibrillation on the Risk of Thrombosis and Bleeding for Patients With Polycythemia Vera and Essential Thrombocytosis in the Real World.

Impact of Atrial Fibrillation on the Risk of Thrombosis and Bleeding for Patients With Polycythemia Vera and Essential Thrombocytosis in the Real World.

Journal: American journal of hematology
Published: January 19, 2026

Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Journal: American journal of hematology
Published: June 23, 2025

Turning universal O into rare Bombay type blood.

Turning universal O into rare Bombay type blood.

Journal: Nature communications
Published: May 05, 2022

Usefulness of NGS for Diagnosis of Dominant Beta-Thalassemia and Unstable Hemoglobinopathies in Five Clinical Cases.

Usefulness of NGS for Diagnosis of Dominant Beta-Thalassemia and Unstable Hemoglobinopathies in Five Clinical Cases.

Journal: Frontiers in physiology
Published: November 11, 2020

Acquired thrombotic thrombocytopenic Purpura diagnosed during first trimester of pregnancy with excellent outcome after plasma exchange and rituximab, a case report.

Acquired thrombotic thrombocytopenic Purpura diagnosed during first trimester of pregnancy with excellent outcome after plasma exchange and rituximab, a case report.

Journal: Clinical case reports
Published: October 03, 2020

Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma.

Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma.

Journal: Leukemia
Published: January 16, 2020

Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination.

Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination.

Journal: Leukemia
Published: May 02, 2019

PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase.

PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase.

Journal: PloS one
Published: March 08, 2017
Showing 1-8 of 8

Last Updated: 09/26/2026